# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(2.45) per share. This is a 41.67 percent increase over losses of...
Senti Biosciences shares are trading higher by 102.6% during Monday's session. The company was awarded $8 million from the ...